Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chromene derivatives and their analoga as Wnt pathway antagonists

Chromene derivatives and their analoga as Wnt pathway antagonists

US Patent 9371333 · Granted Jun 21, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Intracellular kinase associated with resistance against anti-tumour immune respo2025
Cytotoxic T cell response modifiers2023
Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles2019
Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles2019
Chromene derivatives and their analogs as Wnt pathway antagonists2018
Chromene derivatives and their analogs as Wnt pathway antagonists2018
Chromene derivatives and their analogs as Wnt pathway antagonists2018
Chromene derivatives and their analogs as Wnt pathway antagonists2018
Chromene derivatives and their analogs as Wnt pathway antagonists2018
Chromene derivatives and their analogs as Wnt pathway antagonists2018
Cytotoxic T cell response modifiers2018
Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles2018